S. Sasaki‐Hamada

发表

Neoechinulin A induced memory improvements and antidepressant-like effects in mice

F. Sugawara, K. Kuramochi, J. Oka, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of centrally administered glucagon-like peptide-2 on blood pressure and barosensitive neurons in spontaneously hypertensive rats

H. Ishibashi, J. Oka, R. Nakamura, 2018, Neuropeptides.

LARETH-25 and β-CD improve central transitivity and central pharmacological effect of the GLP-2 peptide.

J. Oka, Chihiro Ozawa, Michiko Horiguchi, 2016, International journal of pharmaceutics.

Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents

T. Iwai, T. Sawabe, J. Oka, 2014, Journal of neuroscience research.

Long-term exposure to high glucose induces changes in the expression of AMPA receptor subunits and glutamate transmission in primary cultured cortical neurons.

J. Oka, S. Sasaki-Hamada, Emi Sanai, 2021, Biochemical and biophysical research communications.

Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.

Kinzo Matsumoto, J. Oka, H. Fujiwara, 2013, Journal of pharmacological sciences.

Chotosan, a Kampo formula, ameliorates hippocampal LTD and cognitive deficits in juvenile-onset diabetes rats.

Kinzo Matsumoto, Keita Tamaki, J. Oka, 2014, Journal of pharmacological sciences.

Glucagon-like peptide-2-induced memory improvement and anxiolytic effects in mice

M. Tanabe, A. Saitoh, T. Iwai, 2015, Neuropeptides.

Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines

M. Inagaki, A. Saitoh, Kou Takahashi, 2012, Neuropharmacology.

Excitatory effect of bradykinin on intrinsic neurons of the rat heart

H. Ishibashi, Y. Kadoya, M. Ogata, 2019, Neuropeptides.

Changes in hippocampal synaptic functions and protein expression in monosodium glutamate‐treated obese mice during development of glucose intolerance

J. Oka, Hajime Koyama, S. Sasaki‐Hamada, 2015, The European journal of neuroscience.

Cognitive and hippocampal synaptic profiles in monosodium glutamate-induced obese mice

J. Oka, Hajime Koyama, Shoko Yanagisawa, 2020, Neuroscience Research.

Diabetes onset influences hippocampal synaptic plasticity in streptozotocin-treated rats

J. Oka, S. Sasaki-Hamada, S. Sasaki‐Hamada, 2012, Neuroscience.

Intranasal administration of neuromedin U derivatives containing cell-penetrating peptides and a penetration-accelerating sequence induced memory improvements in mice

K. Yoshizawa, R. Sasaki, J. Oka, 2018, Peptides.

Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test

Kenichi Koizumi, J. Oka, S. Sasaki‐Hamada, 2019, Behavioural Brain Research.

Exendin (5-39), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus

Kazuma Kobayashi, T. Iwai, J. Oka, 2013, Brain Research.

Antidepressant-like effects exerted by the intranasal administration of a glucagon-like peptide-2 derivative containing cell-penetrating peptides and a penetration-accelerating sequence in mice

J. Oka, Michiko Horiguchi, Yusuke Nakao, 2017, Peptides.

Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.

Kaori Ito, J. Oka, S. Sasaki‐Hamada, 2013, Life sciences.

The impairment in spatial learning and hippocampal LTD induced through the PKA pathway in juvenile-onset diabetes rats are rescued by modulating NMDA receptor function

A. Saitoh, M. Yamada, J. Oka, 2014, Neuroscience Research.

Immunohistochemical determination of the site of hypotensive effects of glucagon-like peptide-2 in the rat brain

S. Okada, T. Iwai, J. Oka, 2012, Neuroscience.

GLP-2 restores impairments in spatial working memory and hippocampal LTD via the MEK/ERK pathway in juvenile-onset diabetes rats

T. Iwai, J. Oka, S. Sasaki‐Hamada, 2021, Behavioural Brain Research.

Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice

A. Saitoh, T. Iwai, J. Oka, 2013, Behavioural Brain Research.

Chemical profiling with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia.

Shiro Watanabe, Kinzo Matsumoto, Feng Li, 2015, Journal of pharmaceutical and biomedical analysis.

Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin

J. Oka, S. Sasaki‐Hamada, Masaatsu Ikeda, 2019, Scientific Reports.

Immunohistochemical determination of the site of antidepressant-like effects of glucagon-like peptide-2 in ACTH-treated mice

J. Oka, S. Sasaki‐Hamada, M. Hoshi, 2015, Neuroscience.

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice

Daisuke Yamada, A. Saitoh, T. Iwai, 2022, Neuropsychopharmacology reports.

Riluzole does not affect hippocampal synaptic plasticity and spatial memory, which are impaired by diazepam in rats.

M. Inagaki, A. Saitoh, M. Yamada, 2013, Journal of pharmacological sciences.

Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents

T. Iwai, T. Sawabe, J. Oka, 2014, Journal of neuroscience research.

Effects of centrally administered glucagon-like peptide-2 on blood pressure and barosensitive neurons in spontaneously hypertensive rats

H. Ishibashi, J. Oka, R. Nakamura, 2018, Neuropeptides.

Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.

Kinzo Matsumoto, Azusa Suzuki, J. Oka, 2017, Journal of pharmacological sciences.